Rosco Diagnostica
Rosco Diagnostica is a Danish IVD manufacturer producing Neo-Sensitabs, Diatabs, and resistance-detection kits for clinical microbiology laboratories, hospitals, distributors, and veterinary clinics in over 50 countries, specializing in antibiotic susceptibility testing and bacterial identification to combat antibiotic resistance.
- Company typePrivate
- Founded1970
- HeadquartersAlbertslund, Denmark
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Rosco Diagnostica does
Rosco Diagnostica is a privately held Danish in vitro diagnostics (IVD) manufacturer founded in 1970 and headquartered in Albertslund, Denmark. The company specializes in diagnostic products for clinical microbiology laboratories focused on bacterial and fungal identification and antimicrobial susceptibility testing — explicitly positioned to aid in the fight against antibiotic resistance. Its core portfolio comprises three product lines: Neo-Sensitabs (125+ crystalline antimicrobial and antifungal tablets for disc-diffusion susceptibility testing), Diatabs (80+ enzymatic and conventional tablets for 4-hour bacterial/fungal identification), and Rosco Kits (rapid colorimetric and phenotypic detection kits for ESBL, AmpC, and carbapenemase resistance mechanisms). The proprietary Neo-Sensitabs dry-process crystalline formulation delivers controlled antibiotic release, room-temperature stability, and optical code readability that distinguish it from traditional paper-disc methods. Products are CE-marked under EU IVD Directive 98/79/EC, with documentation maintained to REACH standards.
Rosco operates a B2B sales-led GTM motion, distributing through a network of authorized distributors in more than 50 countries as well as direct sales to hospital laboratories and national health systems. It targets clinical microbiology laboratories, hospitals, distributors, national health surveillance bodies, and (with an expanding veterinary line) veterinary clinics. Marketing relies on a content-rich website, technical documentation (IFU, COA, MSDS), and annual participation at MEDICA (Düsseldorf) and ESCMID (Vienna). Pricing is quote-based and not publicly disclosed; product sales function as one-time consumable transactions (physical diagnostic tablets and kits) rather than subscription or licensing revenue. The company was fully acquired by Alpine-bio on February 29, 2024, and operates with 11–50 employees. Rosco's underlying business model is mature and cash-generative in profile, but small in scale relative to automated susceptibility platforms, with growth dependent on catalog breadth (new antimicrobials, veterinary expansion) and distributor network deepening rather than disruptive technology cycles.
Rosco Diagnostica firmographics
Firmographics- Name
- Rosco Diagnostica
- Legal name
- Rosco Diagnostica ApS
- Website
- https://rosco-diagnostica.com
- Company type
- Private
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Rosco Diagnostica is a Danish IVD manufacturer producing Neo-Sensitabs, Diatabs, and resistance-detection kits for clinical microbiology laboratories, hospitals, distributors, and veterinary clinics in over 50 countries, specializing in antibiotic susceptibility testing and bacterial identification to combat antibiotic resistance.
- Ownership category
- akta.pro rank
Where Rosco Diagnostica is headquartered
LocationHeadquarters
- HQ city
- Albertslund
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
Rosco Diagnostica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic Products Sales: Sale of diagnostic products including Neo-Sensitabs for susceptibility testing, Diatabs for bacterial identification, kits for resistance mechanism detection, reagents, and accessories to clinical laboratories, hospitals, and distributors worldwide.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Direct sales to end customers |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Rosco Diagnostica product offering
Product offeringCore offering
Rosco Diagnostica manufactures and sells in-vitro diagnostic tablets and kits used by clinical microbiology laboratories for bacterial and fungal identification and antimicrobial susceptibility testing. Its portfolio comprises Neo-Sensitabs (over 125 antimicrobial and antifungal susceptibility testing tablets), Diatabs (over 80 rapid enzymatic identification tests with 4-hour results), and Rosco Kits for detecting resistance mechanisms such as ESBLs, AmpC, and carbapenemases via rapid colorimetric and phenotypic methods. Supporting accessories include tablet dispensers for various Petri dish formats.
Product overview
Rosco Diagnostica offers a diagnostic product portfolio consisting of three main product lines: Neo-Sensitabs (antibiotic and antifungal susceptibility testing tablets with over 125 agents), Diatabs (bacterial and fungal identification with over 80 individual tests), and Kits for detection of resistance mechanisms (rapid colorimetric and phenotypic methods for ESBL, AmpC, carbapenemases). The products work together to enable clinical microbiology laboratories to perform complete antimicrobial susceptibility testing and bacterial identification workflows. Supporting accessories include dispensers for various plate sizes. The company also offers specialized veterinary products and reagents.
Differentiator
Problem solved
Functional benefit
Brands
- Diatabs: Diagnostic tablets for rapid identification of Bacteria and Fungi
- Neo-Sensitabs
- ROSCO KITS
Products and services
- Neo-Sensitabs Antibiotic and antifungal susceptibility testing tablets for clinical microbiology laboratories, manufactured using a proprietary dry-process crystalline antimicrobial formulation that provides controlled antibiotic release into agar, long shelf life at room temperature, and large-print 5-figure codes for identification. Available in over 125 different antimicrobial agents and combination tablets, with dedicated ranges for routine susceptibility testing, veterinary use, and antifungal testing, and compatible with CLSI and EUCAST guidelines.
- Diatabs Rapid bacterial and fungal identification system based on microbial enzyme profiles, offering over 80 individual enzymatic and modified conventional tests usable as single tests or in combinations. Delivers 4-hour identification results at up to 50% cost savings versus automated systems, with dedicated bacterial identification tests and a reagents range for in-vitro qualitative procedures.
- Rosco Kits for Detection of Resistance Mechanisms Ready-to-use kits for detecting ESBLs, AmpC, and carbapenemases (KPC and metallo-β-lactamases) in bacterial isolates. Includes rapid colorimetric kits delivering results in 15 minutes to 1 hour (Rapid ESBL Screen Kit, Rapid BLUE CARB Kit, Neo-Rapid CARB Kit) and 18-hour phenotypic confirmatory kits (KPC/MBL Confirm Kit, AmpC Confirm Kit, ESBL+AmpC Screen Kit, Triple disk for KPC+MBL, ESBL Confirm Kits, Total MBL Confirm Kit, Total ESBL+AmpC Confirm Kit, and KPC/MBL in P.aeruginosa/Acinetobacter Kit).
- Tablet Dispensers (Accessories)
- Special Products
Quantifiable outcome
- Rapid identification in 4 hours using Diatabs enzymatic tests
- +3 more outcomes
Companies that use Rosco Diagnostica
Customer profileSegments5 records
Ideal customer profiles4 records
Rosco Diagnostica technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Rosco Diagnostica partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Rosco Diagnostica competitors and assessment
Company assessmentDirect peers
- Condalab: Spanish manufacturer of microbiology products including antimicrobial susceptibility discs and identification systems. Closely comparable specialty manufacturer competing in the same manual susceptibility testing segment as Rosco.
- ELITech Group: European diagnostics company offering microbiology reagents, susceptibility testing products, and identification systems. Directly comparable in product portfolio and target customer segment to Rosco Diagnostica.
- Liofilchem: Italian manufacturer of antibiotic susceptibility discs, identification strips, and MIC strips for clinical microbiology. Directly competes with Rosco's Neo-Sensitabs in disc-diffusion antimicrobial testing and shares the same customer base of hospital and reference laboratories.
- Hardy Diagnostics: US manufacturer and distributor of microbiology products including culture media, susceptibility discs, and identification reagents. Comparable niche specialty manufacturer serving clinical microbiology labs with manual testing consumables.
- Mast Group: UK-based manufacturer of antimicrobial susceptibility discs, identification strips, and culture media for clinical microbiology. Direct peer with similar product format (discs/tablets) and overlapping customer base in hospital microbiology labs.
- Bio-Rad Laboratories: Provides microbiology quality controls and identification/susceptibility testing reagents, including disc-based products. Directly comparable to Rosco in serving clinical microbiology labs with manual susceptibility testing consumables.
Broad incumbents
- Becton Dickinson (BD): Major diagnostics incumbent offering the BD Phoenix automated susceptibility system and manual microbiology products. Targets the same clinical microbiology lab customers as Rosco and competes across both manual and automated susceptibility workflows.
- Beckman Coulter (Danaher): Offers the MicroScan automated identification and susceptibility testing system for clinical microbiology labs. Competes with Rosco in the same hospital lab segment and represents the automated alternative to Rosco's manual disc-diffusion approach.
- bioMérieux: Global leader in microbiology diagnostics, offering automated identification and susceptibility testing systems (e.g., Vitek 2) alongside a broad manual product portfolio that directly overlaps with Rosco's Neo-Sensitabs and Diatabs offerings for clinical microbiology labs.
- Thermo Fisher Scientific: Diversified life sciences giant supplying microbiology consumables, identification panels, and antimicrobial susceptibility products (e.g., Sensititre). Competes broadly with Rosco across manual and automated susceptibility testing workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Rosco Diagnostica compliance and trust
Trust signalCompliance1 record
Rosco Diagnostica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rosco Diagnostica leadership team
Management profileNumber of profiles
Profiles1 record
Rosco Diagnostica funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rosco Diagnostica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rosco Diagnostica
What does Rosco Diagnostica do?
Rosco Diagnostica manufactures and sells in-vitro diagnostic tablets and kits used by clinical microbiology laboratories for bacterial and fungal identification and antimicrobial susceptibility testing. Its portfolio comprises Neo-Sensitabs (over 125 antimicrobial and antifungal susceptibility testing tablets), Diatabs (over 80 rapid enzymatic identification tests with 4-hour results), and Rosco Kits for detecting resistance mechanisms such as ESBLs, AmpC, and carbapenemases via rapid colorimetric and phenotypic methods. Supporting accessories include tablet dispensers for various Petri dish formats.
Is Rosco Diagnostica a public or private company?
Rosco Diagnostica is a private company. It is classified as corporate owned and is currently operating.
When was Rosco Diagnostica founded?
Rosco Diagnostica was founded in 1970. It employs 11 to 50 people.
Where is Rosco Diagnostica based?
Rosco Diagnostica is headquartered in Albertslund, Denmark, in the Europe region.
How does Rosco Diagnostica make money?
One revenue line is on record: diagnostic Products Sales.
Who are Rosco Diagnostica's main competitors?
Direct peers on record are Condalab, ELITech Group, Liofilchem, Hardy Diagnostics, Mast Group and Bio-Rad Laboratories. Broad incumbents are Becton Dickinson (BD), Beckman Coulter (Danaher), bioMérieux and Thermo Fisher Scientific.
Does Rosco Diagnostica have an API?
No public API is recorded for Rosco Diagnostica.